ONC Competitors & Alternatives
Compare BeiGene, Ltd. with similar stocks in the same industry
Biotechnology
ONC
Main Stock$303.96
Tradestie Score
54
Market Cap
$36.81B
P/E Ratio
67.6
Revenue Growth
0.4%
Analyst Upside
+35.7%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$876.25
|
$46.96B | 38.9 | 56 | Compare |
|
INSM
Insmed, Inc.
|
$109.14
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$90.07
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.80
|
$19.56B | 22.1 | 59 | Compare |
|
INCY
Incyte Genomics Inc
|
$114.23
|
$16.93B | 16.5 | 57 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$56.45
|
$15.70B | 29.7 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.30
|
$15.22B | - | 53 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$265.22
|
$12.36B | 31.3 | 61 | Compare |
|
EXEL
Exelixis Inc
|
$56.04
|
$11.09B | 18.7 | 68 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.51
|
$10.76B | - | 67 | Compare |
More ONC Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry